- Home
- CEVA vs QURE Comparison
CEVA vs QURE Comparison
Compare CEVA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CEVA | QURE |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 573.9M | 663.4M |
| IPO Year | 2002 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CEVA | QURE |
|---|---|---|
| Price | $18.37 | $17.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $32.00 | ★ $45.42 |
| AVG Volume (30 Days) | 417.3K | ★ 4.7M |
| Earning Date | 05-19-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,507,000.00 | $13,107,000.00 |
| Revenue This Year | $12.33 | $126.14 |
| Revenue Next Year | $13.94 | $395.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.45 | N/A |
| 52 Week Low | $18.23 | $7.76 |
| 52 Week High | $31.09 | $71.50 |
Technical Indicators
Market Signals| Indicator | CEVA | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 46.00 |
| Support Level | N/A | $13.29 |
| Resistance Level | $24.01 | $26.84 |
| Average True Range (ATR) | 1.05 | 2.09 |
| MACD | -0.12 | 0.25 |
| Stochastic Oscillator | 2.10 | 49.94 |
Price Performance
Historical ComparisonAbout CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.